NDC 0363-0801-00 - Well at Walgreens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0363-0801
- Requested NDC
- 0363-0801-00
- Package NDCs from labels
- 0363-0801-00, 0363-0801-10
- Manufacturer
- Walgreen Company
- Effective date
- 2025-01-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Well at Walgreens - Walgreen Company | Walgreen Company | 2025-01-31 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0363-0801-10 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d0-ca57-f424-e053-dadaa90a57ce | Drug Facts |
| 0363-0801-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ca57-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-0801-00 | Well at Walgreens | 3000 mg in 1 PACKET | POWDER, FOR SOLUTION | 3000 | 20 | |
| 0363-0801-10 | Well at Walgreens | 100 in 1 BOX | POWDER, FOR SOLUTION | 100 | 20 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| SODIUM BICARBONATE | ACTIVE INGREDIENT | 8MDF5V39QO | WELL AT WALGREENS (SODIUM BICARBONATE, SODIUM CHLORIDE) POWDER, FOR SOLUTION [WALGREEN COMPANY] | 12 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | WELL AT WALGREENS (SODIUM BICARBONATE, SODIUM CHLORIDE) POWDER, FOR SOLUTION [WALGREEN COMPANY] | 12 | |
| BICARBONATE ION | ACTIVE MOIETY | HN1ZRA3Q20 | WELL AT WALGREENS (SODIUM BICARBONATE, SODIUM CHLORIDE) POWDER, FOR SOLUTION [WALGREEN COMPANY] | 12 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | WELL AT WALGREENS (SODIUM BICARBONATE, SODIUM CHLORIDE) POWDER, FOR SOLUTION [WALGREEN COMPANY] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | e73b5871-4a87-4473-ab00-5e5395be017d | 2026-10-16 | Warnings | 8MDF5V39QO |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2026-10-16 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries, Inc. | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2026-10-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2026-10-14 | Warnings | 8MDF5V39QO |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 8MDF5V39QO |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X 8MDF5V39QO |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X 8MDF5V39QO |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.